4International Agency for Research on Cancer,World Health Or ganization (WHO). Glohocan 20]2: estimated incidence, mortali ty and prevalence worldwide in 2012EEB/OL. http://glohocan. iarc. fr/Pages/fact_sheets_cancer. aspx,2014-11-1/2015-1-1.
5American College of Radiology. Liver imaging reporting and data system [EB/OL]. http://www, acr. org/QoalitySafety/Re sources/LIRADS,2015 4 27/2015-9-2.
6Tejeda-maldonado J, Garcia-juclrez I, Aguirre valadez J, et al. Diag nosis and treatment of hepatoeellular carcinoma.- an update [J]. World J Hepatol,2015,7(3) :362 376.
7Reiner BI. Medical imaging data reconciliation, Part 4:reconcilia tion of radiology reports and clinical outcomes data[J]. JACR, 2011,8(12) :858-862.
8Darnell A, Forner A, Rimola J, et al. Liver imaging reporting and data system with MR imaging evaluation in nodules 20mm or smaller detected in cirrhosis at screening US[J]. Radiology, 2015, 275(3) 698-707.
9Petruzzi N, Mitchell D, Guglielmo F, et al. Hepatocellular carcino- ma likelihood on MRI exams: evaluation of a standardized catego rization system[J]. Acad Radiol,2013,20(6):694 698.
10Zhang Y,Zhu F,Xu X,et al. Classifying CT/MR findings in pa tients with suspicion of hepatocellular carcinoma: comparison o liver imaging reporting and data system and criteria free likert scale reporting models[J]. J Magn Reson Imaging, 2015,26. DOI 10. 1002/jmri. 24987. [Epub ahead of printS.
